Congestive Heart Failure denials in California external review

In the California DMHC record, independent physician reviewers decided 46 published external-review cases involving congestive heart failureand overturned the plan’s denial in 32.6%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
46
2003–2025
Overturned
32.6%
15 denials reversed

Most-fought treatments for congestive heart failure

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Zoll Life Vest4
25%
Wearable Cardioverter Defibrillator4
50%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
23
21.7%
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
22
40.9%
Typical time to a decision
17 days
Most land between 7 and 21 days
Handled as urgent
28.3%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: An enrollee has requested a LifeVest wearable cardiovascular defibrillator for treatment of the enrollee’s medical condition. Findings: Two physician reviewers found that the patient was presented with three week history of increasing dyspnea on exertion progressing to dyspnea at rest, orthopnea and paroxysmal nocturnal dyspnea. He presented with a new onset atrial fibrillation with rapid ventricular response. The patient underwent transthoracic echocardiogram and transesophageal echo (TEE) which revealed moderately severe global left ventricular (LV) dysfunction, moderately severe mitral insufficiency and left atrial appendage thrombus. The patient also underwent cardiac nuclear study which did not show active ischemia.
Experimental/Investigational · 2016 · IMR EI16-23039
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for LifeVest Wearable Cardioverter Defibrillator (WCD) billed by Zoll Services. This patient presented with newly diagnosed congestive heart failure. The patient was referred for a LifeVest WCD. The provider noted that the patient did not complete three months of guideline directed medical therapy and had an estimated high risk of sudden cardiac death that had the potential to progress over time. Per the current American Heart Association (AHA) guidelines, the use of a WCD for primary prevention of sudden cardiac death is appropriate in patients with non-ischemic cardiomyopathy with left ventricle ejection fraction (LVEF) of 30% or less, on chronic optimal medical therapy.
Experimental/Investigational · 2022 · IMR EI22-38185

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for a wearable cardiovascular defibrillator (Zoll LifeVest) provided Findings: The physician reviewer found that The patient is a patient with a history of smoking, obstructive pulmonary disease and diabetes. The patient presented with dyspnea symptoms due to congestive heart failure. The patient was evaluated with severely depressed left ventricular ejection fraction and subsequent cardiac catheterization. The report noted normal coronary arteries without stenosis. The patient was medically managed and discharged with a wearable defibrillator. A follow up visit reported fatigue and exertional dyspnea. An echocardiogram later reported a left ventricular ejection fraction of 15%. An implantable defibrillator was placed .
Experimental/Investigational · 2017 · IMR EI17-24658
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage to remain in a skilled nursing facility and continue physical therapy for treatment of the enrollee, who has a history of congestive heart failure. Findings: The physician reviewer found that This patient has a history of dilated cardiomyopathy with an ejection fraction of 20-25% and New York Heart Association (NYHA) class III-IV congestive heart failure. He has had multiple episodes of volume overload in the last year requiring intensive diuresis. He was hospitalized with volume overload and pneumonia. He was aggressively treated in the hospital over a week and medically stabilized. He has been receiving care at the skilled nursing facility, primarily for deconditioning. He had made very modest functional progress.
Medical Necessity · 2017 · IMR MN17-25774

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving congestive heart failure, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for congestive heart failure? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39